PharmaBoardroom

Anil Okay – General Manager, Adalvo & Chief Commercial…

CCO Anil Okay introduces how Alvotech’s focus on biosimilars, comprehensive platform, differentiated portfolio approach, and commercial strategy…

Top 20 Companies for Access to Medicine 2021

The Top 20 companies on the 2021 Access to Medicines Index ranked on governance of access, research and development, and product delivery indices.…

EUnetHTA’s Uncertain Future & the Evolution of…

The journey of EUnetHTA began back in 2004, when the European Commission and Council of Minsters requested the establishment of a sustainable European…

Jean-Paul Clozel – CEO, Idorsia

In an exclusive interview, Jean-Paul Clozel explains Idorsia's unique value proposition as a biotech focused on small molecules, how agnosticism in…

Jon Helsdingen – General Manager, AbbVie Switzerland

AbbVie Switzerland's Jon Helsdingen outlines how he has led the Swiss affiliate through a full scale office move, the acquisition and integration of…

Top 10 Global Generics & Biosimilars Companies

The top ten global generics and biosimilars companies according to a recent Informa Pharma Intelligence ranking for 2019. Sandoz leads the way in…

Pharma Country Managers: The COVID Generation

While 2020 may have seemed like the year the world stood still for many, the pharma industry went into overdrive, working around the clock to ensure…

France: ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal;…

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19 vaccine as it faces delays with its…

Population Health: Access & AntiVax Challenges

Vaccines have been touted – and rightly so – as the most cost-effective health intervention after access to clean water. It is estimated by global…

Viatris: Cost-Cutting Needed at New Generics Behemoth

In November 2020, after months of delay caused by COVID-19 disruptions and a US antitrust roadblock, Mylan and Pfizer's Upjohn generics unit finally…

Stefan Hendriks – Global Head Cell & Gene, Novartis…

Stefan Hendriks, Global Head of Novartis Oncology’s Cell & Gene division outlines the company’s progression to becoming the global leader in…

Tim Philippi – Executive Director, Singaporean-German…

The SGC's Dr Tim Philippi introduces the sizeable Singaporean-German trading relationship and the importance of healthcare and the life sciences…

Tagged with